ArticleJournal for immunotherapy of cancer2020

Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition.

Andressa S Laino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.